AlerisLife (NASDAQ:ALR) reported quarterly losses of $(0.34) per share. This is a 477.78 percent decrease over earnings of $0.09 per share from the same period last year.
FDA Denies Adial Pharma’s Fast Track Request For AD04 in Alcohol Use Disorder
Adial Pharmaceuticals Inc (NASDAQ:ADIL) has received notice from the FDA that its request for Fast Track Designation for AD04…